Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer

Transl Lung Cancer Res. 2022 Nov;11(11):2170-2174. doi: 10.21037/tlcr-22-717.

Author

Taiki Hakozaki^{1

2}

Affiliations

¹ Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
² Graduate School of Advanced Science and Engineering, Faculty of Science and Engineering, Waseda University, Tokyo, Japan.

No abstract available

Publication types

Editorial
Comment